Alkermes plc. Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share
Alkermes plc. (ALKS) reported Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share of $0.00 per share for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-10-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare · last filed 2026-02-25
- Alkermes plc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2025-09-30 was $0.00.
- Alkermes plc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2025-06-30 was $0.00.
- Alkermes plc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2025-03-31 was $0.00.
- Alkermes plc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2024-09-30 was $0.00.
- Alkermes plc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2024 was -$0.03.
- Alkermes plc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2023 was -$0.98.
- Alkermes plc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2022 was -$0.76.
- Alkermes plc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2021 was -$0.77.
| Period end | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 3 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 6 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 9 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-10-28 | $0.00 10-Q · filed 2025-10-28 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-07-29 | $0.00 10-Q · filed 2025-07-29 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-01 | |||
| 2024-12-31 | -$0.03 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-10-28 | -$0.04 10-Q · filed 2025-10-28 | ||
| 2024-06-30 | -$0.02 10-Q · filed 2025-07-29 | -$0.03 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | -$0.01 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | -$0.98 10-K · filed 2026-02-25 | |||
| 2023-09-30 | -$0.26 10-Q · filed 2024-10-24 | -$0.70 10-Q · filed 2024-10-24 | ||
| 2023-06-30 | -$0.25 10-Q · filed 2024-07-24 | -$0.43 10-Q · filed 2024-07-24 | ||
| 2023-03-31 | -$0.18 10-Q · filed 2024-05-01 | |||
| 2022-12-31 | -$0.76 10-K · filed 2025-02-12 | |||
| 2021-12-31 | -$0.77 10-K · filed 2024-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |